January 8, 2024 · Form 4 insider transaction
GORMAN KEVIN CHARLES bought 105,835 shares of Neurocrine Biosciences, Inc. at $19.59 per share, a transaction worth $2.07M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.